How much does Ustekinumab cost when it is launched in China?

Ustekinumab (Ustekinumab)The original drug has been approved by the State Food and Drug Administration and is sold under the trade name of Xidanuo. It is included in medical insurance and is only reimbursed for patients who meet the indications, including patients with moderately to severely active Crohn's disease and moderately severe plaque psoriasis. SpecificationsThe price of each box of the 130mg/26ml intravenous injection preparation may be more than 5,000 yuan, the price of each box of the 45mg: 0.5ml*1 subcutaneous injection preparation may be more than 4,000 yuan, and the price of each box of the 90mg: 1.0ml*1 subcutaneous injection preparation may be more than 8,000 yuan.